Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiannao Yizhi Formula (JYF) is a traditional Chinese medicine (TCM) formulation being investigated for the treatment of cognitive impairment, specifically in Alzheimer's disease and vascular dementia. [5] A clinical study comparing JYF to donepezil for mild-to-moderate Alzheimer's disease found that the efficacy and safety of JYF were not inferior to donepezil. [5] The study showed that treatment with the formula increased serum levels of acetylcholine (Ach) and decreased levels of amyloid-β protein 42 (Aβ42) and microtubule-associated protein tau (Tau). [5] Development and clinical research are associated with Chinese institutions, including Wangjing Hospital and Xiyuan Hospital of the China Academy of Chinese Medical Sciences. [5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiannao Yizhi Formula.